Literature DB >> 24689808

Transformation of salvianolic acid B to salvianolic acid a in aqueous solution and the in vitro liver protective effect of the main products.

Shidong Kan1, Zhouzhou Chen, Lei Shao, Ji'an Li.   

Abstract

Salvianolic acid A (Sal A) was considered to be the compound with highest activity in Salvia miltiorrhiza (danshen). Due to its low content in raw materials, many studies reported its preparation from salvianolic acid B (Sal B). However, the process of this transformation is still unknown. Our objective was to find the chemical change of the transformation from Sal B to Sal A. The results showed that Sal B was hydrolyzed to lithospermic acid (LA) first, and the latter was transformed into Sal A in thermal aqueous solution. The radical scavenging ability of Sal A, Sal B, and LA was tested through DPPH, and Sal A showed higher radical elimination ability compared to Sal B and LA. In vitro liver damage was induced by CCl4 in human hepatic WRL68 cell line. Sal A, Sal B, and LA showed liver protective ability in a dose-dependent manner, while Sal A possessed a much higher ability compared to Sal B and LA.
© 2014 Institute of Food Technologists®

Entities:  

Keywords:  antioxidant activity; lithospermic acid; liver protective effect; salvianolic acid A; salvianolic acid B

Mesh:

Substances:

Year:  2014        PMID: 24689808     DOI: 10.1111/1750-3841.12415

Source DB:  PubMed          Journal:  J Food Sci        ISSN: 0022-1147            Impact factor:   3.167


  3 in total

1.  Lithospermic acid attenuates 1-methyl-4-phenylpyridine-induced neurotoxicity by blocking neuronal apoptotic and neuroinflammatory pathways.

Authors:  Yun-Lian Lin; Huey-Jen Tsay; Tzu-Hsuan Lai; Tsai-Teng Tzeng; Young-Ji Shiao
Journal:  J Biomed Sci       Date:  2015-05-28       Impact factor: 8.410

2.  Degradation Kinetics and Mechanism of Lithospermic Acid under Low Oxygen Condition Using Quantitative 1H NMR with HPLC-MS.

Authors:  Jianyang Pan; Xingchu Gong; Haibin Qu
Journal:  PLoS One       Date:  2016-10-24       Impact factor: 3.240

3.  A Cohort Study to Examine the Use of Chinese Herbal Medicine in Combination With Conventional Therapies for Patients With Hepatocellular Carcinoma in China.

Authors:  Lingling Sun; Paul Fahey; Xiaoshu Zhu; Weng Ng; Zhuo Ping Chen; Yiwen Qiu; Hezheng Lai; Jietao Lin; Lizhu Lin
Journal:  Integr Cancer Ther       Date:  2018-05-18       Impact factor: 3.279

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.